Taking Action on PCV2 - BPEX Research Scheme Starts
UK - Just a day into its new role and BPEX Ltd is making a stand with the launch of a 31.5 million PCV2 vaccine research programme. The aim of the project is to find out more about the debilitating infection and its interaction with PMWS and PDNS - persistent diseases that are still evident on many UK farms and holding back progress and improvements to efficiency
2 April 2008
2 minute read
